OGN Organon & Co

  1. Stocks
  2. Healthcare
  3. NYSE: OGN

Price (delayed)

$19.5

Market cap

$4.98B

P/E Ratio

4.86

Dividend/share

$1.12

EPS

$4.01

Enterprise value

$13.05B

Highlights
The equity has soared by 92% YoY and by 88% QoQ
Organon's net income has soared by 75% from the previous quarter and by 12% YoY
The gross margin has contracted by 4.8% YoY
The quick ratio has contracted by 3.4% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of OGN
Market
Shares outstanding
255.64M
Market cap
$4.98B
Enterprise value
$13.05B
Valuations
Price to earnings (P/E)
4.86
Price to book (P/B)
N/A
Price to sales (P/S)
0.79
EV/EBIT
10.88
EV/EBITDA
9.09
EV/Sales
2.08
Earnings
Revenue
$6.26B
EBIT
$1.2B
EBITDA
$1.44B
Free cash flow
$549M
Per share
EPS
$4.01
Free cash flow per share
$2.15
Book value per share
-$0.27
Revenue per share
$24.54
TBVPS
$27.12
Balance sheet
Total assets
$12.06B
Total liabilities
$12.13B
Debt
$8.76B
Equity
-$70M
Working capital
$1.59B
Liquidity
Debt to equity
-125.14
Current ratio
1.54
Quick ratio
0.84
Net debt/EBITDA
5.62
Margins
EBITDA margin
22.9%
Gross margin
59.8%
Net margin
16.3%
Operating margin
19.8%
Efficiency
Return on assets
9.1%
Return on equity
N/A
Return on invested capital
10.2%
Return on capital employed
13.1%
Return on sales
19.2%
Dividend
Dividend yield
5.74%
DPS
$1.12
Payout ratio
27.9%

OGN stock price

How has the Organon stock price performed over time
Intraday
3.56%
1 week
5.86%
1 month
7.56%
1 year
-18.95%
YTD
35.23%
QTD
3.72%

Financial performance

How have Organon's revenue and profit performed over time
Revenue
$6.26B
Gross profit
$3.75B
Operating income
$1.24B
Net income
$1.02B
Gross margin
59.8%
Net margin
16.3%
Organon's net income has soared by 75% from the previous quarter and by 12% YoY
Organon's net margin has soared by 72% from the previous quarter and by 9% YoY
OGN's operating margin is down by 21% year-on-year and by 2.9% since the previous quarter
The company's operating income fell by 20% YoY

Growth

What is Organon's growth rate over time

Valuation

What is Organon stock price valuation
OGN P/E details
P/E
4.86
P/B
N/A
P/S
0.79
EV/EBIT
10.88
EV/EBITDA
9.09
EV/Sales
2.08
The company's EPS has surged by 74% QoQ and by 11% YoY
The price to earnings (P/E) is 26% less than the last 4 quarters average of 6.6
The equity has soared by 92% YoY and by 88% QoQ

Efficiency

How efficient is Organon business performance
The ROA has soared by 69% since the previous quarter and by 6% year-on-year
The return on invested capital has declined by 26% year-on-year
The company's return on sales fell by 23% YoY

Dividends

What is OGN's dividend history
DPS
$1.12
Dividend yield
5.74%
Payout ratio
27.9%
Recent dividends

Financial health

How did Organon financials performed over time
OGN's total assets is up by 10% YoY and by 9% from the previous quarter
OGN's current ratio is down by 6% since the previous quarter
The equity has soared by 92% YoY and by 88% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.